Last reviewed · How we verify

NCT04816448

Effects of Sub-Occipital Myofascial Release in Patients With Cervicogenic Headache

Completed NA Last updated 30 August 2021
What this trial tests

NA trial testing cervical mobilization (Headache SNAG) in Cervicogenic Headache in 22 participants. Completed in 30 December 2020.

Timeline
1 April 2020
Primary endpoint
30 November 2020
30 December 2020

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment22
Start date1 April 2020
Primary completion30 November 2020
Estimated completion30 December 2020
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 20 to 70, any sex, with Cervicogenic Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cervicogenic headache is a secondary form of headache that occurs from the upper cervical spine and atlanto-occipital joint. A CGH is a frequent source of chronic headache and is frequently misdiagnosed .Cervicogenic headache is among the most common problem affecting four times more women as compared to males and is considered by some painful feeling in the head , neck ,temporal area, frontal area and around the eyes areas.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cervicogenic Headache

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04816448.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing